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Abstract.  The intracellular  events regulating en- 
dothelial cell proliferation and organization  into for- 
malized capillaries are not known. We report that the 
protein kinase C  activator [I-phorbol  12,13-dibutyrate 
(PDBu) suppresses bovine capillary endothelial  (BCE) 
cell proliferation (Ks0 =  6  +  4 nM) and DNA synthe- 
sis in response to human hepatoma-derived growth 
factor, an angiogenic endothelial mitogen.  In contrast, 
PDBu has no effect on the proliferation of bovine aor- 
tic endothelial cells and is mitogenic for bovine aortic 
smooth muscle and BALB/c 3T3 cells.  Several obser- 
vations indicate that the inhibition of human 
hepatoma-derived growth factor-stimulated BCE cell 
growth by PDBu is mediated through protein kinase C. 
(a) Different phorbol compounds inhibit BCE cell 
growth according to their potencies as protein kinase 
C  activators (12-O-tetradecanoylphorbol 13-acetate  > 
PDBu >> 13-phorbol  12,13-diacetate  >>> 13-phorbol; 
¢t-phorbol  12,13-dibutyrate;  ~t-phorbol  12,13-didecano- 
ate).  (b) PDBu binds to a  single class of specific, 
saturable sites on the BCE cell with an apparent Kd of 
8 nM,  in agreement with reported affinities of PDBu 
for protein kinase C  in other systems. (c) Specific 
binding of PDBu to BCE cells is displaced by sn-l,2- 
dioctanoylglycerol, a protein kinase C activator and an 
analog of the putative second messenger activating this 
kinase in vivo. The weak protein kinase C  activator, 
sn-l,2-dibutyrylglycerol, does not affect PDBu binding. 
(d) A cytosolic extract from BCE cells contains a cal- 
cium/phosphatidylserine-dependent protein kinase that 
is activated by sn-l,2-dioctanoylglycerol and PDBu, 
but not by 13-phorbol. These findings indicate that pro- 
tein kinase C activation can cause capillary endothelial 
cells to become desensitized to angiogenic endothelial 
mitogens.  This intracellular  regulatory mechanism 
might be invoked during certain phases of angiogene- 
sis, for example when proliferating  endothelial cells 
become differentiated to organize into nongrowing 
tubes. 
GIOGENESIS, the formation of new capillaries,  is rela- 
tively infrequent in normal adult tissues, but dramat- 
ically increases in growing tumors and several other 
pathological  conditions  (reviewed  in Folkman,  1982). An- 
giogenesis  in vivo requires not only increased  proliferation 
of capillary  endothelial  cells but also organization  of these 
cells into nonproliferating,  differentiated blood vessels (Folk- 
man et al., 1982). Endothelial cell proliferation  is stimulated 
in vitro by two classes of heparin-binding  growth factors that 
have been isolated from a variety of sources and are structur- 
ally related to fibroblast growth factor (Shing et al.,  1984; 
Gospodarowicz et al.,  1984; D;Amaore and Klagsbrun,  1984; 
Maciag et al., 1984; Sullivan and Klagsbrun,  1985; reviewed 
in Lobb et al.,  1986 and Thomas et al.,  1986). Since many 
of these mitogens cause angiogenesis  in the rat or rabbit cor- 
nea and  the chick embryo (D~,more,  1982; Shing  et al., 
1985; Klagsburn et al., 1986), it has been postulated that they 
are endogenous angiogenic  factors.  While capillary endo- 
thelial cell growth control is clearly a very important compo- 
nent of in  vivo angiogenesis,  the intracellular  events  that 
regulate endothelial cell response to angiogenic mitogens are 
not known. 
In the present study, we have investigated the role of the 
phospholipid/calcium-dependent protein kinase (protein ki- 
nase C) in capillary  endothelial  cell growth.  In many other 
cell types, protein kinase C is thought to be involved in mi- 
togenesis. Several agents, including mitogens such as plate- 
let-derived growth factor and bombesin, cause increased hy- 
drolysis  of phosphatidylinositol-4,5-bisphosphate  in  their 
target  cells  (Berridge  and  Irvine,  1984; Berridge,  1984; 
Michell,  1982; Berridge et al.,  1984). One of the putative 
second messengers released upon phosphatidylinositol-4,5- 
bisphosphate hydrolysis is sn-l,2-diacylglycerol,  which acti- 
vates protein kinase C by increasing  its affinity for calcium 
(Nishizuka,  1984). Certain phorbol diesters are potent acti- 
vators of protein kinase C, binding at the same site as diacyl- 
glycerol (Castagna  et al.,  1982), and,  it has been suggested 
that most, if not all,  of the biological effects of these com- 
pounds are due to protein kinase  C activation  (Nishizuka, 
1984; Kikkawa et al., 1983). One of these actions is the stim- 
ulation of cell division in such cell types as Swiss 3T3 cells 
(Rozengurt et al., 1984; Dicker and Rosengurt,  1980), lym- 
phocytes (Kaibuchi et al.,  1985; Gelfand et al.,  1985), thy- 
roid cells  (Bachrach  et al.,  1985), and chick heart mesen- 
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exert their stimulatory effect in synergy with suboptimal con- 
centrations of serum or other mitogens. 
We have found that 13-phorbol 12,13-dibutyrate  (PDBu) ~ 
and other protein kinase C  activators inhibit,  rather than 
stimulate, the proliferation of bovine capillary endothelial 
(BCE) cells in response to angiogenic endothelial mitogens 
such as  human hepatoma-derived growth  factor (HDGF; 
Klagsbrun et al., 1986). In addition, we present evidence that 
the PDBu receptor in BCE ceils shares several characteris- 
tics, including diacylglycerol specificity, with protein kinase 
C. These findings imply that this protein kinase may be in- 
volved in an intracellular regulatory mechanism to suppress 
the response of endothelial ceils to angiogenic mitogens. We 
suggest that such a mechanism might be invoked during en- 
dothelial cell differentiation into nonproliferating capillary 
tubes. 
Materials and Methods 
Materials 
Tris  base,  Hepes,  EGTA,  EDTA,  p-toluenesulfonylfluoride, aprotinin, 
BSA, and histone (type IIIS) were purchased from Sigma Chemical Co. (St. 
Louis, MO). Phorbol compounds were from Sigma Chemical Co. or from 
LC Services Corporation (Woburn, MA). The sodium salt of  ATP was from 
P-L Biochemicals (Piscataway,  NJ). [y-32p]ATE  [20-3H(N)]phorbol 12,13- 
dibutyrate,  [3H-methyl]thymidine,  [2-3H(N)]myo-inositol,  [5,6,9,11,12,14, 
15-3H]arachidonic  acid, and [3H]toluene  were from Dupont-New England 
Nuclear (Boston, MA).  SDS and 2-mercaptoethanol were from Bio-Rad 
Laboratories  (Richmond,  CA).  Thin-layer chromatography  plates  were 
from EM Reagents (Cincinnati, OH). Tissue culture reagents were from 
Gibco (Grand Island, NY). Highly purified human HDGF was prepared by 
Robert Sullivan and Dr. Michael Klagsbrun, Departments of Surgery and 
Biological Chemistry, The Children's Hospital and Harvard Medical School 
(Klagsbrun et al., 1986). The specific activity of  this factor was 5 U/rig, with 
1 U eliciting half-maximal stimulation of 3T3 cell DNA synthesis as de- 
scribed by Klagsbrun and Shing (1985).  sn-l,2-Dioctanoylglycerol (DiCs) 
and phosphatidylserine (PS) were obtained from Avanti Polar Lipids, Inc. 
(Birmingham, AL).  sn-l,2-Dibutyrylglycerol (DiC4)  was synthesized en- 
zymatically and purified as described by Ebeling et al. (1985), using dibut- 
yrylphosphatidylcholine from Avanti Polar Lipids, Inc., and phospholipase 
C  (type XIII)  from Sigma Chemical Co.  The concentrations of diacyl- 
glycerol or phorbol diester in stock solutions were measured by an ester de- 
termination procedure using alkaline hydroxylamine and ferric perchlorate 
(Kates,  1972). All other reagents were from Fisher Scientific Co.  (Pitts- 
burgh, PA). 
Cell Culture 
BCE cells were isolated from bovine adrenal glands and cultured as de- 
scribed by Folkman et al. (1979), except that 5 ~tl/ml retinal extract (Gitlin 
and DAmore,  1983; D~nore et al.,  1981) was substituted for the mouse 
sarcoma-conditioned medium. Bovine aortic endothelial cells and bovine 
aortic smooth muscle cells were isolated and grown as described previously 
(Folkman et al., 1979; Voyta et al., 1984). BALB/c 3T3 cells were obtained 
from Dr. Michael Klagsbrun. 
Cell Proliferation  Assays 
Cell  proliferation assays  were  performed in  gelatinized 24-well  dishes 
(Nunc, Roskilde, Denmark) as previously described (Klagsbrun and Shing, 
1985;  Shing et ai.,  1984).  Unless otherwise specified, the medium was 
DME with 10 % calf serum. PDBu or other phorbol compounds were added 
as solutions in dimethylsulfoxide (Me2SO).  Me,  SO was added to all test 
1. Abbreviations  used  in this paper:  BCE,  bovine adrenal  capillary en- 
dothelial; DiC4, sn-l,2-dibutyrylglycerol; DiCs, sn-l,2-dioctanoylglycerol; 
HDGF,  human hepatoma-derived growth factor; M~SO,  dimethylsulfox- 
ide; PDBu, 13-phorbol 12,13-dibutyrate;  PIP2,  phospatidylinositol-4,5-bis- 
phosphate; PS, phosphatidylserine. 
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Figure  I.  Inhibition of capillary  endothelial cell proliferation by 
phorbol dibutyrate. The BCE cell proliferation assay was performed 
as described in Materials and Methods, with 15,000 cells plated per 
well. The number of attached cells per well when test substances 
were added was 14,100  +  600 (n  =  8). Ceils were incubated with 
test substances for 72 h before cell counts were determined. Assays 
were performed with (solid circles) or without (open circles) 10 U/ 
well of human HDGF (Klagsbrun et al.,  1986).  The results given 
are the means  +  SEM of quadruplicate wells. 
solutions and controls so that the final concentration was identical in all 
wells (<1%). After incubation with test substances for the indicated times, 
cells were trypsinized and counted using a cell counter (Coulter Electronics, 
Hialeah, FL). All assays were performed in quadruplicate. 
Reversibility of  PDBu Treatment 
Cells were plated (50,000  cells/well) on a gelatinized 6-weU dish (35-ram 
diameter wells) and were incubated overnight in DME-10 % calf serum. The 
following day, the medium was changed to DME-10 % calf serum containing 
either 0.001% MeaSO (three wells) or 20 nM PDBu, 0.001% M~SO (three 
wells). The cells were incubated for 72 h, then the medium was replaced 
with DME-10 % calf serum for 48 h. The ceils from each experimental con- 
dition were trypsinized, pooled, and counted. Complete detachment of both 
types of cells was confirmed by light microscopy. The total cell number was 
5.5  x  105 for the control and  1.3  x  105 for the PDBu-treated cultures. 
Cells were plated on gelatinlzed 24-well dishes at 10,000 cells/well (12 wells 
per condition) and were incubated in BCE growth medium. The medium 
was changed after 24 h and every 48 h thereafter. At each time point (1, 3, 
5, and 7 d after plating) the cell numbers in control and PDBu-treated wells 
were determined. To compare growth rates, the logarithms of cell numbers 
(determined in triplicate wells) were plotted versus time (in days). 
DNA Synthesis Assays 
For experiments measuring the incorporation of [3H]thymidine  into acid- 
precipitable material, cells were plated in gelatinized 24-well dishes (16-mm 
wells) at 15,000 cells/well. For autoradiography, cells were plated at equiva- 
lent densities on gelatinized 35-mm dishes or tissue culture chamber/slides 
(LabTek;  Miles, Laboratories, Elkhart, IN).  Unless otherwise indicated, 
the medium was DME with 1% calf serum and 0.1% Me,  SO. Cells were 
incubated  with  [3H-methyl]thymidine and  other test  substances  as  de- 
scribed in the figure legends. For determining acid-precipitable radioactiv- 
ity, the medium was aspirated and the cells were washed with Dulbecco's 
PBS. The cells were then washed twice for 5 rain with cold acetic acid/meth- 
anol (1:3) and twice for 10 min with cold 10% TCA. The precipitates were 
then washed with water and dissolved in three successive 0.15-ml aliquots 
of 0.3 N NaOH. For each well, these aliquots were pooled and added to 
4 ml scintillation fluid (ReadySolv MP; Beckman Instruments, Inc., Fuller- 
ton, CA) containing 20 gl glacial acetic acid. Samples were counted for 
tritium in a scintillation spectrometer (LS 3801; Beckman Instruments, Inc.) 
and  data were corrected for quenching using the H-number calibration 
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washed with PBS and fixed successively in Karnovsky's fixative and  1% 
OsO4. Slides or dishes were washed in water and allowed to air dry. Fixed 
cell monolayers were coated with Kodak Nuclear Track Emulsion, type 
NTB. After at least 1 wk exposure, the emulsions were developed and fixed 
according to the manufacturer's instructions. 
PDBu Binding to BCE Cells 
Cells were plated in gelatinized 24-well plates (16-mm diameter wells) at 
15,000 cells/well and were incubated for 3-4 d in DME-10% calf serum. 
Immediately before binding assays were conducted, the cells from two or 
three wells were trypsinized and the average cell number was determined. 
The medium was aspirated from the remaining wells and the cells were 
washed with  1 ml PBS.  The PISS was removed and replaced with [20- 
3H(N)]phorbol  12,13-dibutyrate  (13HIPDBu)  in 0.3  ml  DME  with 0.1% 
BSA and 25 mM Hepes, pH 7.4.  For concentrations >30 riM, nonradioac- 
tive PDBu was added as a carrier. For each concentration of PDBu tested, 
nonsaturable binding was determined in the presence of 20 ~tM unlabeled 
PDBu.  Nonradioactive PDBu, when present, was added as a solution in 
Me,  SO and [~H]PDBu  was added as a  solution in ethanol.  (The radio- 
chemical purity of [3H]PDBu  was confirmed by thin-layer chromatography 
on silica plates developed in toluene/acetone [3:1] followed by autoradiogra- 
phy.) Me2SO and ethanol were added to all test solutions so that the final 
concentrations were 1 and 0.8%, respectively. The cells were incubated at 
37°C  for the indicated times, the medium was aspirated,  and  the cells 
washed three times with 1 ml cold 0.9% NaC1, 50 mM Tris-HCl, pH 7.4. 
The cells were solubilized in three successive aliquots of 0.15 rni  1% SDS. 
For each well, these aliquots were pooled and counted in 15 ml of ReadySolv 
MP scintillation fluid.  Data were corrected for quenching as described 
above. Maximal binding of PDBu under these conditions occurred within 
60 rain and remained stable for at least 180 rain. 
Preparation of  BCE Cytosol 
All procedures were carried out at 4°C. Cells from two confluent 75-cm  2 
flasks were detached by incubation with agitation in PBS with 0.5  mM 
EDTA for 20 rain, followed by gentle scraping with a cell scraper (Costar, 
Cambridge, MA). The cells (1.5 ×  107 cells) were collected by centrifuga- 
tion and were resuspended in 0.5 ml of extraction buffer (50 mM Tris-HC1, 
pH 7.5, 0.5 mM EGTA, 2 mM EDTA, 1 mM p-toluenesulfonylfluoride, 20 
mM 2-mercaptoethanol, and 10 ~tg/ml aprotinin). The mixture was homog- 
enized in a 1-ml Dounce micro tissue grinder (Reactiware; Pierce Chemical 
Co., Rockford, IL), using five strokes with the A pestle. The tissue grinder 
was washed with an additional 1 mi extraction buffer, and the combined ho- 
mogenate was centrifuged at 1,000 g for 10 rain. The supernatant was set 
aside, and the pellet was resuspended in  1 ml extraction buffer and cen- 
trifuged in the same manner as above.  The pooled  1,000-g  supernatants 
(3-ml volume) were centrifuged at 100,000 g for 30 rain. The resulting cyto- 
solic supernatant was desalted by two successive cycles of concentration (to 
,',,50-100  lal) and dilution (to 2 ml with extraction buffer minus aprotinin) 
in a  (10-kD  tool wt cutoff)  microconcentration apparatus (Centricon 10; 
Amicon, Danvers, MA). The concentration steps were performed by cen- 
trifugation at 3,000 g for 2-4 h. The final cytosolic protein solution was col- 
lected and the membrane washed with extraction buffer, yielding a final vol- 
ume of  400 ~tl. The protein concentration was determined with the Bio-Rad 
protein assay (Bio-Rad Laboratories), with BSA as a standard. 
Protein Kinase Assays 
Cytosolic preparations from BCE cells were incubated at 35°C in a reaction 
mixture containing 50 mM Tris-HCl, pH 7.5, 10 mM MgCI2,  0.5 mg/mi 
histone (type IIIS;  Sigma Chemical Co.), 50 ~tM [y-32p]ATE  and other 
substances as indicated. PS and DiCs were sonicated in water before addi- 
tion to reactions. Reactions were terminated by spotting aliquots onto phos- 
phocellulose filter paper (P81; Whatman, Inc., Clifton, NJ) and immedi- 
ately washing with 75 mM phosphoric acid. The spotting and filtration were 
done in a Minifold apparatus (Schleicher and Schuell, Inc., Keene, NH) un- 
der vacuum.  The filter paper was then removed from the apparatus and 
washed in 75 mM phosphoric acid. Spots were cut out from the filter paper 
and counted for 32p in 4  ml ReadySolv EP scintillation fluid. When de- 
sired, the amount of [T-32p]ATP remaining in the reaction mixtures was 
determined by thin-layer chromatography as described previously (Doctrow 
and Lowenstein, 1985). 
Measurement of  lnositol Phosphate Production 
by BCE Cells 
BCE cells (200,000  cells/well) were plated in DME-10%  calf serum in 
35-mm gelatinized tissue culture wells. After cells were attached, the me- 
dium was replaced with 1.5 ml DME-10%  calf serum containing 10-25 
~tCi/ml  [2-3H(N)]-myo-inositol (3H-inositol).  (In  later  experiments, the 
medium was 10%  DME-90%  inositol-free DME [GIBCO special order] 
with 10% calf serum.) After prelabeling for 48 h, the cells were incubated 
for 30 rain in PBS with 15 mM LiCI2 (Besterman et al.,  1986). The me- 
dium was then replaced with 1 rni PBS with or without HDGF (20 U). At 
this time, zero time samples were prepared by removing medium from some 
wells  and  adding  1  rnl  extraction  solution  (chloroform/methanol/HCl; 
1:2:0.05).  For each condition, duplicate or triplicate wells were prepared. 
The experimental wells were incubated for 20 min, then quenched with ex- 
traction solution as described for the zero time samples. All dishes were ex- 
tracted for 20 min at room temperature, then washed twice with I ml extrac- 
tion solution. Phase separation was achieved by adding 800 Ixl chloroform 
and 800 ~tl 1.2 N HCI. The aqueous phase was removed and the organic 
phase washed twice as described previously (Doctrow and Lowenstein, 
1985). The washes were pooled with the aqueous phase and the solvent was 
removed in a Speed-Vac (Savant Instruments, Inc., Hicksville, NY) without 
heat. The water-soluble inositol phosphates were separated by ion exchange 
chromatography and the peaks corresponding to inositol monophosphate, 
inositol diphosphate, and inositol triphosphate were collected and counted 
as described previously (Berridge, 1983). To assess incorporation of [3H]- 
inositol into phosphatidylinositol, phosphatidylinositol-4-phosphate, and 
phosphatidylinositol-4,5-bisphosphate (PIP2),  the  organic  layers  were 
dried down and subjected to thin-layer chromatography in system III (DOC- 
trow and Lowenstein, 1985) followed by autofluorography. 
Results 
PDBu inhibited the proliferation of BCE cells in a concentra- 
tion-dependent manner (Fig. 1). In the absence of PDBu, the 
cells grew very slowly in serum alone, in agreement with 
previous reports (Folkman et al., 1979), while HDGF caused 
their growth rate to nearly triple.  Even in the presence of 
HDGE however, PDBu potently inhibited BCE cell growth. 
The concentration of the phorbol ester required to inhibit the 
number of  population doublings by 50% was 6 +  4 nM (four 
separate  proliferation experiments).  Cells  were  examined 
daily by phase-contrast microscopy and there was no indica- 
tion that PDBu caused increased cell detachment. Allowing 
BCE cells to attach to culture dishes for 6 h in the presence 
of  200 nM PDBu did not affect cell plating efficiency. PDBu- 
treated cells and untreated cells stained equally well with the 
viability indicator fluorescein diacetate. In addition, PDBu- 
mediated growth inhibition was reversible. When BCE cells 
that had been incubated for 72 h in PDBu were removed from 
the phorbol ester and replated as described in Materials and 
Methods, PDBu-treated and control cells replated with simi- 
lar efficiencies and grew at identical rates (data not shown). 
To examine cell  specificity, we compared the  effect of 
PDBu on BCE cell proliferation with its effect on that of two 
other vascular cell types, bovine aortic endothelial cells, and 
bovine aortic smooth muscle cells. In contrast to its potent 
inhibition of BCE cells (Fig. 2 A), PDBu did not affect the 
proliferation of aortic endothelial cells (Fig.  2  B) even at 
1 ILM. The proliferation of aortic smooth muscle cells was 
also not inhibited by PDBu  (Fig.  2  C),  but was,  in fact, 
slightly stimulated. 
In shorter term assays for DNA synthesis, PDBu was also 
effective in inhibiting the response to HDGF. Fig. 3 shows 
that PDBu inhibited the incorporation of radioactive thymi- 
dine by BCE cells in response to increasing concentrations 
of HDGE Inhibition by even suboptimal (15 nM) PDBu was 
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butyrate on proliferation  of vas- 
cular cells.  Cell proliferation  as- 
says were performed as described 
in  Materials  and  Methods.  Re- 
suits  are the  means  +  SEM  of 
quadruplicate  wells.  No  is  the 
number of cells attached per well 
at  the  beginning  of the  experi- 
ment.  (A)  BCE  cells,  plated  at 
30,000 cells/well  were incubated 
for 72 h with test substances.  (B) 
Bovine  aortic  endothelial  cells, 
plated  at 30,000 ceUs/weU (stip- 
pled  bar)  and  7000  cells/well 
(open  bar),  and  incubated  for 
48 h with test substances.  (C) Bo- 
vine aortic smooth muscle cells, 
plated  at 7,000 cells/well  and in- 
cubated  for 72  h  with  test  sub- 
stances. 
not overcome by high levels (20 U/ml) of HDGF. Autoradio- 
graphic analysis confirmed the inhibition of HDGF action by 
PDBu. In the absence of factor, cells showed a  basal DNA 
synthetic level corresponding to <20 % labeled nuclei (Fig. 
4).  The percent of cells undergoing DNA synthesis was in- 
creased over threefold in the presence of HDGF. Addition of 
PDBu  essentially  eliminated  the  HDGF-stimulated  DNA 
synthesis with no apparent effect on the basal level.  In the 
presence or absence of HDGF, cells treated with PDBu dis- 
played  a  morphological  change,  extending  long  processes 
(not shown). 
While phorbol esters have been reported to increase cell 
growth in synergy with other mitogens,  in this  case PDBu 
and HDGF showed antagonistic rather than synergistic ac- 
tions.  This does not seem to be true in all cases of growth 
stimulation by this  class of mitogen.  In quiescent BALB/c 
3T3  fibroblasts,  DNA  synthesis  was  stimulated  by  both 
PDBu and HDGF (Table I). Kaibuchi et al.  (1985) recently 
showed  that  the  stimulation  of Swiss  3T3  cell  growth  by 
fibroblast growth factor (a growth factor structurally related 
if not identical to HDGF; Lobb et al.,  1986) may involve ac- 
tivation of protein kinase  C. 
Since the inhibition of growth factor action is not a typical 
effect of protein kinase C  activators, we further investigated 
the phorbol diester-induced inhibition of  BCE cell prolifera- 
tion for evidence that it was due to protein kinase C  activa- 
tion. We tested five different phorbol derivatives to determine 
whether there was a correlation between protein kinase C ac- 
tivators and inhibitors of BCE cell response to HDGF (Table 
II).  The potent  protein  kinase  C  activator  12-O-tetradeca- 
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Figure 3. Effect of phorbol dibutyrate on the concentration-depen- 
dent response  of capillary endothelial  cells  to HDGF.  BCE cells 
were incubated for 24 h in medium containing 2 ~tCi/ml [3H-meth- 
yl]thymidine  and HDGF and PDBu as indicated.  Incorporation of 
radioactivity  into acid-precipitable  material  was determined as de- 
scribed in Materials  and Methods. Each value represents  the mean 
5: SEM of triplicate wells. The concentrations of PDBu were (solid 
circles) 0 nM; (open circles) 15 nM; and (open triangles)  150 nM. 
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Figure 4,  Phorbol dibutyrate- 
mediated suppression of  growth 
factor-stimulated  DNA  syn- 
thesis by capillary endothelial 
cells.  BCE  cells  were  incu- 
bated for 18 h in medium con- 
taining, where indicated, 20 U/ 
ml HDGF and 150 nM PDBu. 
Cells were labeled for an addi- 
tional  3  h  with  [3H-methyl] 
thymidine  (2  ~tCi/ml) before 
processing for either  autora- 
diography (open bars) or quan- 
titation  of  acid-precipitable 
radioactivity  (striped bars) as 
described in Materials  and Methods.  Autoradiography  results are 
expressed as percent labeled nuclei with each value representing  the 
mean +  SEM for at least five fields containing  35-85 cells.  The 
acid-precipitable  radioactivity per cell is expressed  as percent of a 
maximal value arbitrarily defined as 50 dpm tritium incorporated 
per cell. Cell numbers were determined in parallel wells by Coulter 
counting. 
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PDBu or HDGF 
Treatment  [3H]Thymidine incorporation 
dpm 
None  949  +  74 
PDBu  59,288  ±  1,733 
HDGF  33,198  ±  1,084 
PDBu +  HDGF  111,186 ±  6,350 
Incorporation of [3H]thymidine  by quiescent  BALB/c  3T3  cells  was deter- 
mined as described previously (Klagsbrun and Shing,  1985).  The wells con- 
tained  0.1%  Me2SO  and,  where  indicated,  30  nM  PDBu  and 4  U  per ml 
HDGF. Each value represents the mean  ±  SEM for quadruplicate wells. 
noylphorbol 13-acetate (TPA) inhibited BCE cell proliferation 
slightly more than PDBu, with both causing >75 % suppres- 
sion at 100 nM. ffPhorbol and ¢t-phorbol 12,13-didecanoate, 
which  do  not  activate  protein  kinase  C  (Castagna  et  al., 
1982), had no significant effect on BCE cell proliferation at 
100 nM. At the same concentration, 13-phorbol  12,13-diace- 
rate,  a  weak  protein  kinase  C  activator  (Noguchi  et  al., 
1985), only slightly inhibited BCE cell proliferation. Similar 
relative potencies were observed for all compounds at 10 nM 
(data not shown). Another compound tested was ~t-phorbol 
12,13-dibutyrate,  an  inactive  stereoisomer  of  PDBu  and 
therefore perhaps the most suitable control compound. This 
PDBu isomer had no effect on HDGF-stimulated prolifera- 
tion or DNA synthesis at concentrations as high as 2  ~tM 
(data not shown). 
We next investigated binding of PDBu to BCE cells using 
a  radioactive  ligand-binding  assay.  BCE  cells  exhibited 
specific, saturable binding of PDBu in the same concentra- 
tion range as that causing inhibition of proliferation (Fig. 5). 
Scatchard analysis of these data revealed that PDBu bound 
at a single class of sites with an apparent Kd of ~8 nM. The 
maximal binding of PDBu was  '~85 fmol/llY cells,  or '~5 
x  105 receptors per cell. 
As noted above, phorbol diesters bind protein kinase C at 
the same site as the enzyme's presumed endogenous activa- 
tor, sn-l,2-diacylglycerol (Nishizuka,  1984; Kikkawa et al., 
1983).  Recently,  a  series  of synthetic diacylglycerols have 
~'o  ~  ~o 
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Figure 5.  [3H]PDBu  binding 
to BCE cells. Binding was de- 
termined as described in Mate- 
rials and Methods, with 33,000 
cells/well  and  an  incubation 
time of 120 min.  The results 
shown are the mean  +  SEM 
of triplicate determinations  or 
the mean of  duplicate determi- 
nations  that agreed to within 
5 %.  Nonsaturable binding  of 
[3H]PDBu, also determined in 
triplicate,  has been subtracted  from each value. Nonsaturable bind- 
ing was  28  :t:  1 fmol/105 cells  at  13 nM  [3H]PDBu and  104  + 
12 fmol/105 cells at 48 nM [3H]PDBu. 
r  i  : 
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Figure 6.  Inhibition  of [3H]- 
PDBu binding to capillary en- 
dothelial  cells  by  sn-l,2-dia- 
cylglycerols.  Binding of [3H]- 
PDBu to BCE cells was mea- 
sured  as  described  in  Mate- 
rials and Methods with 39,000 
cells/well,  10 nM [3H]PDBu, 
and an incubation time of 60 
min. Diacylglycerols  in Me2SO 
were added to the binding me- 
dium and the mixtures were sonicated before further dilution.  Non- 
saturable binding of [3H]PDBu, determined in triplicate,  was sub- 
tracted from each value.  Shown is the binding of [3H]PDBu to 
BCE cells in the presence of DiCs (solid circles) and DiC4 (open 
circles). Each value is the mean +  SEM of three determinations. 
been evaluated as activators of protein kinase C.  The most 
potent of these is DiCs, which activates isolated protein ki- 
nase C, displaces PDBu from its receptor, and evokes a num- 
ber of cellular responses that have been attributed to protein 
kinase C activation (Ganong and Bell,  1985; Ebeling et al., 
1985;  Davis  et  al.,  1985;  Lapetina  et  al.,  1985).  Diacyl- 
glycerols with shorter chain lengths are much weaker. In par- 
Table II. Comparison of Effects of  Different Phorbol Compounds on Protein Kinase C Activity and HDGF-induced 
Capillary Endothelial  Cell Proliferation 
Percent protein kinase C  activation 
Phorbol compound  Cell  No.  Percent inhibition*  (Noguchi et al.,  1985)  (Castagna et al.,  1982) 
None (control)  78,900  ±  1,600  -  -  - 
13-Phorbol 12, 
13-dibutyrate  19,700 ±  800  77  75  88 
12-O-Tetradeca- 
noylphorbol 
13-acetate (13)  14,100 ±  400  96  95  100 
13-Phorbol  76,900  ±  3,500  I  0  0 
a-Phorbol 12, 
13-didecanoate  71,600  ±  3,100  4  -  0 
13-Phorbol 
12,13-diacetate  56,600  ±  3,400  18  25  - 
BCE cell  proliferation assays were performed as described in Materials and Methods, with 17 U  HDGF per well and 100 nM phorbol compound. The number 
of attached cells per well when test substances were added was 13,000. Cell numbers are the means +  SEM of quadruplicate wells. Previously published in vitro 
protein kinase C  activation data were determined by Noguchi et al.  (1985)  at 20 nM and Castagna et al.  (1982) at  10 ng/ml. 
* Inhibition  =  1 -  (number of cell doublings with phorbol compound)/(number of cell  doublings in control). 
Number of cell  doublings  =  log2 (cell  number at 72 h)/(initial cell  number). 
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cytosolic protein kinase C by 
DiCs  or phorbol  dibutyrate. 
Protein kinase activity was as- 
sayed as described  in Mate- 
rials and Methods with 50 ~tM 
[7-32p]ATP (1,350 dpm/pmol), 
12  lag protein/ml  BCE cyto- 
solic preparation, and, where 
indicated, 200 lag/ml  PS, 2 mM 
EGTA, 20  ~tg/ml DiC8, and 
50  nM  PDBu or 13-phorbol. 
Under  these  conditions,  the 
rate  of protein  phosphoryla- 
tion was constant for at least 
60 min (data not shown). Pro- 
tein  phosphorylation  is  ex- 
pressed as the amount of 32p 
incorporated into histone dur- 
ing 50 min/50-ktl aliquot. Each value given is the mean  +  SEM 
for quadruplicate aliquots. All values have been corrected for basal 
protein kinase activity by subtracting the amount of 32p incorpo- 
rated in the absence of PS, EGTA, DiC8, or phorbol compounds 
(4,200  +  200 dpm). 
ticular, DiC4 is two to three orders of magnitude less potent 
than DiC8 in activation of protein kinase C and in displac- 
ing PDBu from its receptor (Ebeling et al.,  1985). 
We therefore tested DiC8  and  DiC4  for displacement of 
PDBu from its receptor in BCE cells. We found (Fig. 6) that 
DiC8 displaced over 90% of the specific binding of PDBu, 
with 50% displacement occurring at 9  gM DiC8.  DiC4,  in 
accordance with its known low affinity for protein kinase C, 
did not displace PDBu from BCE cells at concentrations as 
high as 80 I.tM. Attempts to evaluate the effect of DiC8 on 
BCE  cell growth  were unsuccessful.  DiCa,  at  concentra- 
tions of 100 IxM or less, was rapidly metabolized in the cell 
cultures (as assessed by the ability of the culture medium 
to displace [3H]PDBu binding), whereas higher concentra- 
tions  of DiC8  caused  cell  rounding  and  irreversible  de- 
tachment. 
These results are consistent with an interaction of PDBu 
with protein kinase C in BCE cells. To show that this enzyme 
exists in the BCE cell and that it is activated by PDBu, we 
prepared a cytosolic extract from BCE cells as described in 
Materials  and  Methods.  In preliminary experiments (data 
not shown), we found that this preparation contained protein 
kinase activity that required both calcium and PS, i.e., pro- 
tein kinase C activity. We tested the BCE cytosolic protein 
kinase C  activity to determine whether it was activated by 
PDBu or diacylglycerol. Other studies have shown that both 
of these compounds increase the affinity of protein kinase C 
for calcium, causing it to become more active at suboptimal 
calcium concentrations (Nishizuka,  1984; Kishimoto et al., 
1980). We assayed a BCE cytosolic preparation under condi- 
tions where submaximal protein kinase C activity was ob- 
served in the presence of PS and endogenous calcium (Fig. 
7). This protein kinase C activity was increased by ~200% 
when DiC8 was added. The DiC8-stimulated protein kinase 
activity required PS  and  was  abolished by EGTA.  PDBu 
stimulated BCE cytosolic protein kinase C in a manner simi- 
lar to DiC8,  while I~-phorbol at the same concentration had 
no effect. Hydrolysis of radioactive ATP in these reactions, 
as determined by thin-layer chromatography (Doctrow and 
Lowenstein,  1985),  was insignificant (<5 %). 
As discussed above, many mitogens induce PIP2 hydroly- 
sis  in their target cells. It is therefore possible that HDGF 
might act via such a mechanism in BCE cells. If this were 
true, then the phorbol ester-induced inhibition observed by 
us might be a feedback inhibition of phospholipase C, similar 
to that proposed in other systems (Brock et al.,  1985; Rosoff 
and Cantley,  1985).  To test whether HDGF stimulates PIP2 
hydrolysis in  BCE cells,  we incubated  [3H]inositol  prela- 
beled cells with and without HDGF and measured radioac- 
tive  inositol  phosphates  as  described  in  Materials  and 
Methods. In the presence or absence of HDGF, we observed 
no changes in inositol phosphate levels compared with those 
present before test incubations. For example, in one experi- 
ment, the amount of inositol phosphate recovered from the 
cells was 236,600 +  8,400 cpm/well inositol monophosphate 
and 12,400  +  600 cpm/well inositol polyphosphates before 
and after 30 min incubation with HDGF (20 U) or PBS con- 
trol solutions. Similarly, no changes in inositol phosphates 
were detected after incubation times of 15 s,  5 min, or  10 
min. We also conducted experiments using cells prelabeled 
with  radioactive arachidonic  acid  to  detect diacylglycerol 
production as previously described (Kaibuchi et al.,  1986). 
We found no change in diacylglycerol levels in the controls 
or in the HDGF-treated BCE cells. 
Discussion 
These results demonstrate that PDBu strongly attenuates the 
mitogenic response of BCE cells to  the basic  endothelial 
mitogen HDGF (Figs.  1, 3, and 4).  We have also observed 
a  similar  effect on  the  response of these  cells  to  retina- 
derived growth  factor (Doctrow,  S.  R.,  and  J.  Sudhalter, 
unpublished  observations),  an  acidic  endothelial  mitogen 
which, like HDGF and related factors, is angiogenic in vivo 
(DAmore,  1982).  These  were unexpected findings,  since 
PDBu and other protein kinase C activators are mitogenic or 
co-mitogenic for many other cell types (Dicker and Rozen- 
gurt,  1980;  Kaibuchi  et  al.,  1985;  Gelfand et  al.,  1985; 
Bachrach et al., 1985; Balk et al., 1984) including the bovine 
aortic  smooth  muscle  cells  (Fig.  2  C)  and  BALB/c  3T3 
fibroblasts (Table I) that we tested. (This is not, however, the 
first example of a cell whose growth is inhibited by phorbol 
diesters. These compounds inhibit the proliferation of HL-60 
promyeloid leukemia cells, concomitantly causing them to 
differentiate into cells with the properties of normal macro- 
phages  [Huberman  and  Callahan,  1979; Ebeling  et  al., 
1985] .) 
In contrast to its  potent inhibition of BCE cell growth, 
PDBu had no effect on the proliferation of bovine aortic en- 
dothelial cells (Fig. 2 B). This lack of effect is not likely to 
be due to a protein kinase C deficiency in the aortic cells, 
since phorbol diesters at nanomolar concentrations induce a 
morphological change in bovine aortic endothelial cells and 
cause them to produce plasminogen activator (Gross et al., 
1982). In addition, Mackie et al. (1986) have measured pro- 
tein kinase C in extracts from bovine aortic endothelial and 
bovine  pulminary  arterial  endothelial  cells  and  report  a 
specific activity (0.27  +  0.02 nmol/mg protein per min) in 
agreement with that measured by us in BCE preparations 
(~0.2 nmol/mg protein per min). While the reason for the 
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aortic endothelial cells is not clear,  it may indicate some 
specificity of PDBu-mediated growth inhibition for small 
vessel endothelium. 
A number of our observations suggest that PDBu interacts 
with BCE cells through protein kinase C. Inhibition of BCE 
cell growth occurred at PDBu concentrations well within the 
range of those shown to increase protein kinase C in other 
systems (Rozengurt et al., 1983; Kikkawa et al., 1983). Vari- 
ous phorbol compounds inhibited HDGF-mediated growth 
with an order of potency that correlated very closely with 
their known relative potencies as activators of isolated pro- 
tein kinase C  (Table II). 
Our binding studies (Fig. 5) revealed that PDBu interacts 
with a specific, saturable receptor on BCE cells. The appar- 
ent dissociation constant for this interaction (8 nM) agrees 
with the Ks0 for the inhibition of BCE cell growth (6  +  4 
nM). It is therefore likely that the receptor detected in our 
binding studies mediates the growth effect. The PDBu recep- 
tor in BCE cells has affinity for the protein kinase C-activat- 
ing diacylglycerol DiCs, but not for the inactive DiC4 (Fig. 
6).  The concentration range of DiC8 required to compete 
with PDBu  for binding to BCE cells is equivalent to that 
needed to displace PDBu  from A431  cells (Davis et al., 
1985) and HL-60 cells (Ebeling et al., 1985), two cell types 
in which PDBu is thought to exert its effects via protein ki- 
nase C.  In addition,  similar concentrations of DiC8 have 
been shown to activate protein kinase C in intact platelets 
(Lapetina et al.,  1985). Because an sn-l,2-diacylglycerol is 
the  postulated  endogenous  activator  of protein  kinase  C 
(Nishizuka, 1984), the affinity of the PDBu receptor in BCE 
cells for DiC8 is perhaps the most important piece of evi- 
dence that this receptor is indeed protein kinase C. This in- 
terpretation is strengthened by the observation that DiCa,  a 
very weak protein kinase C activator (Ebeling et al.,  1985; 
Lapetina et al., 1985), did not displace PDBu binding even 
though both DiC4 and PDBu are dibutyryl esters. 
This study also demonstrates that protein kinase C can be 
detected enzymatically in a BCE cytosolic preparation and 
that the enzyme is activated by PDBu (Fig. 7). This was not 
unexpected since protein kinase C has been found in many 
different tissues.  However,  our data eliminate the remote 
possibility that BCE cells are either lacking in protein kinase 
C or contain a similar enzyme that is unresponsive to diacyl- 
glycerols or phorbol diesters. 
We were unable to detect HDGF-induced changes in inosi- 
tol phosphate or diacylglycerol levels in BCE cells. We con- 
clude that HDGE while stimulating BCE cell growth, does 
not seem to cause PIP2 hydrolysis under our conditions. Al- 
though we used techniques that have successfully demon- 
strated mitogen-induced PIP2 hydrolysis in other systems, 
we cannot exclude the possibility that a functionally impor- 
tant, but minor, pool of messenger is being masked in our 
experiments. But, presently, we have no evidence that HDGF 
activates protein kinase C in these cells, which is consistent 
with our observation that HDGF and phorbol diesters do not 
have a synergistic or additive effect in our experiments. 
The molecular mechanisms of BCE cell growth stimula- 
tion by HDGF and its inhibition by protein kinase C remain 
unknown. Our data indicate a protein kinase C-mediated un- 
coupling of HDGF from its intracellular effects, essentially 
desensitizing the endothelial cells to mitogens. This desen- 
sitization might involve down-regulation of HDGF receptors 
or disruption of one or more of the intracellular events re- 
quired to transduce the mitogenic signal to the nucleus. It is 
not likely that PDBu competes directly with a single step in 
the normal signal transduction cascade of HDGF, because 
very high amounts of growth factor do not overcome inhibi- 
tion by even subsaturating concentrations of PDBu (Fig. 3). 
PDBu-induced down-regulation of protein kinase C, a phe- 
nomenon reported in certain other cells (Kaibuchi et al., 
1986), does not explain our results, since PDBu pretreatment 
completely inhibits DNA synthesis in BCE cells without af- 
fecting their [3H]PDBu binding capacity (data not shown). 
A process that can render capillary endothelial cells insen- 
sitive to mitogens is likely to be crucial to the formation of 
functional capillaries. Angiogenesis in vivo requires not only 
endothelial cell proliferation, but also organization of these 
cells  into  nonproliferating tubes  (Folkman et  al.,  1982). 
When capillary endothelial cells are induced to form tubes 
in culture, they have a greatly reduced rate of mitosis com- 
pared with cells that are not organizing in this fashion (Folk- 
man and Haudenschild, 1980; Madri, et al., 1983). In vivo, 
growing capillary networks consist of proliferating endo- 
thelial cells that are often in close proximity to nonprolifer- 
ating, tube-forming cells (Ausprunk and Folkman,  1977). 
Thus,  mechanisms must exist for locally suppressing the 
growth of certain endothelial cells even in the presence of 
significant amounts of mitogen. It is possible that protein ki- 
nase C activation is an intracellular signal inducing endothe- 
lial cells to become desensitized to angiogenic endothelial 
mitogens and perhaps, as discussed below, to organize into 
tubes. Inasmuch as tube formation is considered a more dif- 
ferentiated state than proliferation for endothelial cells (Madri 
et al.,  1983),  protein  kinase C  activation in  response  to 
specific localized signals (e.g., extraceUular matrix compo- 
sition) may promote differentiation in these cells. 
Previously reported effects of  TPA on capillary endothelial 
cells  support  a  phorbol  diester-induced  differentiation. 
When a capillary endothelial cell monolayer on the surface 
of a collagen gel is treated with TPA, the cells organize into 
capillary-like tubes  inside the  gel  (Montesano  and  Orci, 
1985). TPA causes capillary endothelial cell monolayers to 
produce proteases, which may allow them to modify their 
substratum and invade tissues during certain phases of  angio- 
genesis (Gross et al., 1982). The TPA-induced effects leading 
to tube formation and protease production occur indepen- 
dently of cell growth, and therefore are consistent with our 
present observation that protein  kinase C  activation sup- 
presses the proliferation of these cells in response to mito- 
gens.  Most recently, Lombardi et al.  (1986) have demon- 
strated  that  TPA  induces  cultured  BCE  cells  to  exhibit 
diaphragmed fenestrae,  a  differentiated characteristic that 
was previously difficult to demonstrate in vitro. 
These previous reports, together with our present findings, 
suggest that protein kinase C activation may be one intracel- 
lular signal for switching capillary endothelial cells from a 
proliferative into a more differentiated state. The precise role 
played by protein  kinase C  in angiogenesis is  not easily 
predicted by in vitro experiments. It is highly unlikely that 
indiscriminate activation of this kinase in a population of en- 
dothelial cells would be sufficient to trigger the construction 
of a  complete vascular system in vivo, especially since it 
would inhibit their proliferation. However, selective modula- 
Doctrow and Folkman Protein  Kinase C and Capillary  Endothelial  Growth  685 tion of this enzyme  during appropriate stages of angiogenesis 
might help to direct this complex process. We speculate that 
protein kinase C-induced uncoupling  of mitogen action is 
one important step promoting endothelial cell organization 
into mature,  nongrowing capillaries. 
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